Tag Archives: Arrowhead Research

April, 2015

  • 13 April

    FDA Clears Arrowhead to Continue its Hepatitis B Trial

    Pasadena-based Arrowhead Research Corporation announced that US health regulators gave the company the green light to continue with its mid-stage hepatitis B infection study. The company said that the US Food and Drug Administration (FDA) informed the company that it can proceed with a multiple-dose Phase 2b clinical study of …

March, 2015

  • 5 March

    Novartis Sells its RNAi Assets to Arrowhead Research

    Today, Arrowhead Research Corporation announced that it has acquired Novartis’ entire RNAi business for $10 million in cash and $25 million in stock. The deal gives Arrowhead Novartis’ complete RNAi research and development portfolio and associated assets, including assignment of certain Novartis patents and patent applications related to RNAi therapeutics, …